Biniszkiewicz Detlev 4
4 · iTeos Therapeutics, Inc. · Filed Jul 24, 2020
Insider Transaction Report
Form 4
Biniszkiewicz Detlev
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-07-23+16,608→ 0 totalExercise: $19.00Exp: 2030-07-23→ Common Stock (16,608 underlying)
Footnotes (1)
- [F1]This stock option shall vest over 3 years, with 1/3 vesting on July 23, 2021 and thereafter in equal monthly installments over the next 24 months subject to the Reporting Person's continued service to the Issuer.